2020 SITC Cancer Immunotherapy Winter School Schedule

The following is the schedule for the 2020 SITC Cancer Immunotherapy Winter School, taking place Jan. 13–17, 2020 in Houston.

5-Day Program
Days 1 & 2 (Jan. 13–14, 2020) – Basic tumor immunology and cancer immunotherapy topics

Days 3, 4, & 5 (Jan. 15–17, 2020) – In-depth topics with multi-track structure

*Indicates a session that is not eligible for CME/CE credit.

Enduring Materials Available now available to SITC Members!

As a benefit for attending the 2020 Cancer Immunotherapy Winter School, the Society for Immunotherapy of Cancer (SITC) provides enduring materials free of charge.

Attendees and SITC Members can access the presentation slides and video for Winter School by clicking on the presentation links below.

Open Access Availability*

If you are a SITC member, or member of the general public, but did not attend the 2020 Cancer Immunotherapy Winter School, the enduring materials are now available for purchase by clicking here.
Enduring materials will become available to SITC members 30 days after the program on February 17, 2020.
Enduring materials will become open access 90 days after the program on April 17, 2020.

If you have questions about 2020 Cancer Immunotherapy Winter School enduring materials, please contact education@sitcancer.org.

Presentations with this symbol were not permitted to be posted.

Return to ...

SITC WINTER SCHOOL HOME

Schedule

Monday, Jan. 13, 2020

8:00 – 8:30 a.m.	Registration and Breakfast Ballroom AB
8:30 – 9:00 a.m.	Welcome Ballroom AB
9:00 – 10:00 a.m.	Immunotherapy Overview: History of the Field Michael T. Lotze, MD – University of Pittsburgh Ballroom AB
10:00 – 10:10 a.m.	Break
10:10 – 11:10 a.m.	Innate Immunity: Cellular Mechanisms and Signaling Lewis Lanier, PhD – University of California San Francisco Ballroom AB
11:10 a.m. – 12:10 p.m.	Adaptive Immunity: Cellular Mechanisms and Signaling Olivera Finn, PhD – University of Pittsburgh Ballroom AB
12:10 – 1:00 p.m.	Lunch - Roundtables with Faculty Ballroom AB
1:00 – 2:00 p.m.	Tumor Microenvironment: Complexity of Cells and Molecules Regulating Intratumoral Immunity Victor H. Engelhard, PhD – University of Virginia School of Medicine Ballroom AB
2:00 – 3:00 p.m.	Tumor Immunosuppression Mechanisms Greg M. Delgoffe, PhD – University of Pittsburgh Ballroom AB
3:00 – 3:15 p.m.	Break
3:15 – 4:15 p.m.	Tumor Immunology, Immunoregulation, and Immunopharmacodynamics Jay A. Berzofsky, MD, PhD – National Cancer Institute Ballroom AB
4:15 – 5:15 p.m.	Antigen Presentation Olivera Finn, PhD – University of Pittsburgh San Felipe A	T Cell Exhaustion Greg M. Delgoffe, PhD – University of Pittsburgh San Felipe B	Innate Immune Mechanisms Dendritic Cells and NK Cells Lewis Lanier, PhD– University of California San Francisco Ballroom AB

Tuesday, Jan. 14, 2020

8:30 – 8:55 a.m.	Registration/Breakfast Ballroom AB
8:55 – 9:00 a.m.	Welcome Back Ballroom AB
9:00 – 10:00 a.m.	Immunotherapeutic Strategy: Immune Checkpoint Blockade Sumit K. Subudhi, MD, PhD – The University of Texas MD Anderson Cancer Center Ballroom AB
10:00 – 10:10 a.m.	Break
10:10 – 11:10 a.m.	Immunotherapeutic Strategy: Adoptive Cell and CAR T Therapies Catherine Bollard, MD – Baylor College of Medicine Ballroom AB
11:10 a.m. – 12:10 p.m.	Presenting Your Data in Talks and Manuscripts Jennifer Wargo MD MMSc – The University of Texas MD Anderson Cancer Center Ballroom AB
12:10 – 1:00 p.m.	Lunch Roundtables Ballroom AB
1:00 – 2:00 p.m.	Preclinical Assessment of Cell and Gene Therapy Products to Support IND Feorillo Galivo, PhD - U.S. Food and Drug Administration Ballroom AB
2:00 – 3:00 p.m.	Immunity and Therapeutic Efficacy Jerome Galon, PhD – Universite Pierre Et Marie Curie, Sorbonne Universites Ballroom AB
3:00 – 3:15 p.m.	Break
3:15 – 4:15 p.m.	Cytokine-based Immunotherapies and Other Molecular Bispecifics, Other Immunotherapies Michael T. Lotze, MD – University of Pittsburgh Ballroom AB	T Cell Agonists Andrew Weinberg, PhD – Earle A. Chiles Research Institute San Felipe A	The Microbiome and Immunotherapy Jennifer Wargo MD MMSc – The University of Texas MD Anderson Cancer Center San Felipe B
4:30 – 6:00 p.m.	Welcome Reception Ballroom AB Foyer

Wednesday, Jan. 15, 2020

8:00 – 8:25 a.m.	Registration/Breakfast Ballroom AB
8:25 – 8:30 a.m.	Welcome Back Ballroom AB
8:30 – 9:30 a.m.	Immunotherapeutic Strategy: Can Cancer Vaccines Really Work? Lisa H. Butterfield, PhD – The Parker Institute for Cancer Immunotherapy/University of California San Francisco Ballroom AB
9:30 – 10:30 a.m.	Data and Statistical Analyses: Analyzing Basic and High Throughput Nikesh Kotecha, PhD – The Parker Institute for Cancer Immunotherapy Ballroom AB
10:30 – 10:40 a.m.	Break
10:40 – 11:40 a.m.	Researchers' Track– Antigen Identification Victor H. Engelhard, PhD – University of Virginia School of Medicine San Felipe A	Clinicians' Track– Phase I Immunotherapy Clinical Trials Howard L. Kaufman, MD, FACS – Massachusetts General Hospital San Felipe B
11:40 a.m. – 12:30 p.m.	Lunch Roundtables
12:30 – 1:30 p.m.	Researchers' Track – Pre-Clinical Mouse Models of Cancer Immunotherapy Anthony Rongvaux, PhD – Fred Hutchinson Cancer Research Center San Felipe A	Clinicians' Track – Phase II and III Immunotherapy Clinical Trials Daniel P. Normolle, PhD – University of Pittsburgh San Felipe B
1:30 – 2:30 p.m.	Researchers' Track – Clinical Trial Basics De-Coded Leisha A. Emens, MD, PhD - UPMC Hilllman Cancer Center San Felipe A	Clinicians' Track – How to Get a Predictive Biomarker out of Every Clinical Trial Lisa H. Butterfield, PhD – PICI Research Center, Parker Institute for Cancer Immunotherapy; University of California, San Francisco San Felipe B
2:30 – 2:45 p.m.	Break

2:45 – 3:45 p.m.

Deep TCR and BCR Sequencing as a Biomarker for Cancer
Sacha Gnjatic, PhD – Ichan School of Medicine at Mount Sinai
San Felipe A

Industry-Led Session: New Agents*
Ginna G. Laport, MD – Tempest Therapeutics
Ballroom AB

Patient Considerations that Impact Treatment & Clinical Trials
Deborah Collyar - Patient Advocates in Research
San Felipe B

Thursday, Jan. 16, 2020

8:00 – 8:25 a.m.	Registration/Breakfast Ballroom AB
8:25 – 8:30 a.m.	Welcome Back Ballroom AB
8:30 – 9:30 a.m.	Grantsmanship Christian Capitini, MD – University of Wisconsin-Madison Ballroom AB
9:30 – 9:40 a.m.	Break
9:40 – 10:40 a.m.	Researchers' Track – Tumor Cell Analyses (Pathology) Jerome Galon, PhD – Universite Pierre Et Marie Curie, Sorbonne Universites San Felipe A	Clinicians' Track – Autoimmunity and irAEs Michael A. Morse, MD – Duke University Medical Center San Felipe B
10:40 – 11:40 a.m.	Researchers' Track – Applications of Computational Biology/Machine Learning to Immuno-Oncology Takis Benos, PhD—University of Pittsburgh San Felipe A	Clinicians' Track – Biomarker-Based Clinical Trials* Jianda Yuan, MD, PhD – Merck San Felipe B
11:40 a.m. – 12:30 p.m.	Lunch Roundtables Ballroom AB
12:30 – 1:30 p.m.	Intratumoral and Local Therapy Howard L. Kaufman, MD, FACS – Massachusetts General Hospital Ballroom AB
1:30 – 2:30 p.m.	Researchers' Track – Synthetic Immunology: Harnessing the Tools of Synthetic Biology and Gene Editing to Engineer Next-Generation Cell Therapies Justin Eyquem, PhD—University of California, San Francisco San Felipe A	Clinicians' Track – Immunotherapy in Special Patient Populations Michael A. Morse, MD – Duke University Medical Center San Felipe B
2:30 – 3:30 p.m.	Researchers' Track – Pre-Clinical Combination Immunotherapy Taha Merghoub, PhD — Memorial Sloan Kettering Cancer Center San Felipe A	Clinicians' Track – Clinical Endpoints Michael A. Morse, MD – Duke University Medical Center San Felipe B
3:30 – 3:45 p.m.	Break

3:45 – 4:45 p.m.

Hands On Dataset Analysis (Bring Your Own Datasets)
Takis Benos, PhD – University of Pittsburgh
San Felipe A

Development of a Translational Idea
Sumit K. Subudhi, MD, PhD – MD Anderson Cancer Center
San Felipe B

Methods to Assess and Discover Biomarkers*
Jianda Yuan, MD, PhD – Merck
Ballroom AB

Friday, Jan. 17, 2020

8:00 – 8:25 a.m.	Registration/Breakfast Ballroom AB
8:25 – 8:30 a.m.	Welcome Back Ballroom AB
8:30 – 9:30 a.m.	Cancer Immunotherapy: An FDA Perspective Raj Puri, MD, PhD, FDA, CBER – U.S. Food and Drug Administration Ballroom AB
9:30 – 10:30 a.m.	GMP: It’s Not Science, It’s Manufacturing Lisa H. Butterfield, PhD – The Parker Institute for Cancer Immunotherapy/University of California San Francisco Ballroom AB
10:30 – 10:40 a.m.	Break
10:40 – 11:40 a.m.	Researchers' – Track How to Handle Big Data and High-Throughput Data Nikesh Kotecha, PhD – The Parker Institute for Cancer Immunotherapy San Felipe A	Clinicians' Track – Combination Immunotherapies Leisha A. Emens, MD, PhD – UPMC Hillman Cancer Center San Felipe B
11:40 a.m. – 12:30 p.m.	Lunch Roundtables Ballroom AB
12:30 – 1:30 p.m.	How to Work with Patient Representatives to Make Your Research More Successful Deborah Collyar – Patient Advocates in Research Ballroom AB

1:30 – 2:30 p.m.	Career Development Awards Christian Capitini, MD – University of Wisconsin-Madison Ballroom AB	Careers in Industry* Ginna Laport, MD – Tempest Therapeutics San Felipe A	Careers in Government Raj Puri, MD, PhD, FDA, CBER – U.S. Food and Drug Administration San Felipe B
2:30 – 2:40 p.m.	Break
2:40 – 3:40 p.m.	Perspective on Direction of the Field Christian Capitini, MD – University of Wisconsin - Carbone Cancer Center Ballroom AB
3:40 – 3:50 p.m.	Closing Ballroom AB